677 related articles for article (PubMed ID: 7626351)
1. Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment.
Lip GY; Lowe GD; Rumley A; Dunn FG
Br Heart J; 1995 Jun; 73(6):527-33. PubMed ID: 7626351
[TBL] [Abstract][Full Text] [Related]
2. Effects of fixed low-dose warfarin, aspirin-warfarin combination therapy, and dose-adjusted warfarin on thrombogenesis in chronic atrial fibrillation.
Li-Saw-Hee FL; Blann AD; Lip GY
Stroke; 2000 Apr; 31(4):828-33. PubMed ID: 10753983
[TBL] [Abstract][Full Text] [Related]
3. Effects of warfarin therapy on plasma fibrinogen, von Willebrand factor, and fibrin D-dimer in left ventricular dysfunction secondary to coronary artery disease with and without aneurysms.
Lip GY; Lowe GD; Metcalfe MJ; Rumley A; Dunn FG
Am J Cardiol; 1995 Sep; 76(7):453-8. PubMed ID: 7653443
[TBL] [Abstract][Full Text] [Related]
4. Fibrin D-dimer and beta-thromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation. Effects of introducing ultra-low-dose warfarin and aspirin.
Lip GY; Lip PL; Zarifis J; Watson RD; Bareford D; Lowe GD; Beevers DG
Circulation; 1996 Aug; 94(3):425-31. PubMed ID: 8759084
[TBL] [Abstract][Full Text] [Related]
5. Plasma fibrinogen and fibrin D-dimer in patients with atrial fibrillation: effects of cardioversion to sinus rhythm.
Lip GY; Rumley A; Dunn FG; Lowe GD
Int J Cardiol; 1995 Oct; 51(3):245-51. PubMed ID: 8586473
[TBL] [Abstract][Full Text] [Related]
6. Activation of coagulation occurs after electrical cardioversion in patients with chronic atrial fibrillation despite optimal anticoagulation with warfarin.
Jacob K; Talwar S; Copplestone A; Gilbert TJ; Haywood GA
Int J Cardiol; 2004 May; 95(1):83-8. PubMed ID: 15159043
[TBL] [Abstract][Full Text] [Related]
7. A study of platelet activation in atrial fibrillation and the effects of antithrombotic therapy.
Kamath S; Blann AD; Chin BS; Lanza F; Aleil B; Cazenave JP; Lip GY
Eur Heart J; 2002 Nov; 23(22):1788-95. PubMed ID: 12419299
[TBL] [Abstract][Full Text] [Related]
8. A prospective randomized trial of aspirin-clopidogrel combination therapy and dose-adjusted warfarin on indices of thrombogenesis and platelet activation in atrial fibrillation.
Kamath S; Blann AD; Chin BS; Lip GY
J Am Coll Cardiol; 2002 Aug; 40(3):484-90. PubMed ID: 12142115
[TBL] [Abstract][Full Text] [Related]
9. Fibrinogen and fibrin D-dimer levels in paroxysmal atrial fibrillation: evidence for intermediate elevated levels of intravascular thrombogenesis.
Lip GY; Lowe GD; Rumley A; Dunn FG
Am Heart J; 1996 Apr; 131(4):724-30. PubMed ID: 8721646
[TBL] [Abstract][Full Text] [Related]
10. Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients.
Roldán V; Marín F; Muiña B; Torregrosa JM; Hernández-Romero D; Valdés M; Vicente V; Lip GY
J Am Coll Cardiol; 2011 Jun; 57(25):2496-504. PubMed ID: 21497043
[TBL] [Abstract][Full Text] [Related]
11. Plasma von Willebrand factor, soluble thrombomodulin, and fibrin D-dimer concentrations in acute onset non-rheumatic atrial fibrillation.
Marín F; Roldán V; Climent VE; Ibáñez A; García A; Marco P; Sogorb F; Lip GY
Heart; 2004 Oct; 90(10):1162-6. PubMed ID: 15367514
[TBL] [Abstract][Full Text] [Related]
12. Relation of endothelium, thrombogenesis, and hemorheology in systemic hypertension to ethnicity and left ventricular hypertrophy.
Lip GY; Blann AD; Jones AF; Lip PL; Beevers DG
Am J Cardiol; 1997 Dec; 80(12):1566-71. PubMed ID: 9416937
[TBL] [Abstract][Full Text] [Related]
13. Is diastolic dysfunction associated with thrombogenesis? A study of circulating markers of a prothrombotic state in patients with coronary artery disease.
Lip GY; Lowe GD; Metcalfe MJ; Rumley A; Dunn FG
Int J Cardiol; 1995 Jun; 50(1):31-42. PubMed ID: 7558462
[TBL] [Abstract][Full Text] [Related]
14. Thrombogenesis in mitral regurgitation and aortic stenosis.
Lip GY; Rumley A; Dunn FG; Lowe GD
Angiology; 1996 Dec; 47(12):1117-25. PubMed ID: 8956663
[TBL] [Abstract][Full Text] [Related]
15. Indexes of hypercoagulability measured in peripheral blood reflect levels in intracardiac blood in patients with atrial fibrillation secondary to mitral stenosis.
Li-Saw-Hee FL; Blann AD; Goldsmith I; Lip GY
Am J Cardiol; 1999 Apr; 83(8):1206-9. PubMed ID: 10215285
[TBL] [Abstract][Full Text] [Related]
16. Nonvalvular atrial fibrillation: evidence for a prothrombotic state.
Kahn SR; Solymoss S; Flegel KM
CMAJ; 1997 Sep; 157(6):673-81. PubMed ID: 9307553
[TBL] [Abstract][Full Text] [Related]
17. Fibrin D-dimer, tissue-type plasminogen activator, von Willebrand factor, and risk of incident stroke in older men.
Wannamethee SG; Whincup PH; Lennon L; Rumley A; Lowe GD
Stroke; 2012 May; 43(5):1206-11. PubMed ID: 22382157
[TBL] [Abstract][Full Text] [Related]
18. D-dimer and factor VIIa in atrial fibrillation - prognostic values for cardiovascular events and effects of anticoagulation therapy. A RE-LY substudy.
Siegbahn A; Oldgren J; Andersson U; Ezekowitz MD; Reilly PA; Connolly SJ; Yusuf S; Wallentin L; Eikelboom JW
Thromb Haemost; 2016 May; 115(5):921-30. PubMed ID: 26818781
[TBL] [Abstract][Full Text] [Related]
19. Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Effects of cardioversion and return of left atrial function.
Li-Saw-Hee FL; Blann AD; Gurney D; Lip GY
Eur Heart J; 2001 Sep; 22(18):1741-7. PubMed ID: 11511124
[TBL] [Abstract][Full Text] [Related]
20. Validity of plasma fibrinogen, D-dimer, and the von Willebrand factor as markers of cardiovascular morbidity in patients on chronic hemodialysis.
Kirmizis D; Tsiandoulas A; Pangalou M; Koutoupa E; Rozi P; Protopappa M; Barboutis K
Med Sci Monit; 2006 Feb; 12(2):CR55-62. PubMed ID: 16449948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
